Claims for Patent: 6,197,051

Summary for Patent: 6,197,051

Title:	Polycarbonate-polyurethane dispersions for thromobo-resistant coatings
Abstract:	A medical device is described which has on a surface thereof a bio-compatible coating. This bio-compatible coating is formed from a composition which includes an aqueous emulsion or dispersion of a polycarbonate-polyurethane composition containing one or more internal emulsifying agents.
Inventor(s):	Zhong; Sheng-Ping (Northboro, MA)
Assignee:	Boston Scientific Corporation (Natick, MA)
Application Number:	09/248,307
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,197,051
Patent Claims:	1. A medical device having a surface, said surface having a bio-compatible coating thereon, said bio-compatible coating formed from a composition comprising an aqueous emulsion or dispersion of a polycarbonate-polyurethane polymer, said polycarbonate-polyurethane polymer having thereon one or more emulsifying agents which include at least one organic acid functional group. 2. The medical device of claim 1, wherein said one or more emulsifying agents comprise one or more organic acid functional groups selected from the group consisting of free carboxylic acid, free sulfonic acid, free phosphoric acid and combinations thereof. 3. The medical device of claim 2, wherein said bio-compatible coating comprises a polyfunctional cross-linking agent, and further wherein a portion of said polyfunctional cross-linking agent is covalently bonded to said one or more organic acid functional groups on said polycarbonate-polyurethane polymer and an excess of said polyfunctional cross-linking agent is not covalently bonded to said one or more organic acid functional groups on said polycarbonate-polyurethane polymer. 4. The medical device of claim 3, wherein said polyfunctional cross-linking agent is selected from the group consisting of polyfunctional aziridines, polyfunctional carbodiimides and mixtures thereof. 5. The medical device of claim 4, wherein said bio-compatible coating contains a second coating composition which comprises a bio-active agent having one or more organic acid functional groups which are covalently bonded to said excess polyfunctional cross-linking agent. 6. The medical device of claim 5, wherein said bio-active agent is selected from the group consisting of thrombo-resistant agents, antibiotic agents, anti-tumor agents, growth hormones, antiviral agents, anti-angiogenic agents, angiogenic agents, anti-mitotic agents, anti-inflammatory agents, cell cycle regulating agents, genetic agents, hormones, and chemically modified equivalents and combinations thereof. 7. The medical device of claim 6, wherein said bio-active agent is selected from the group consisting of heparin, heparin sulfate, hirudin, hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, urokinase, streptokinase, and chemically modified equivalents and combinations thereof. 8. The medical device of claim 6, wherein said bio-active agent is selected from the group consisting of penicillins, cephalosporins, vancomycins, aminoglycosides, quinolones, polymyxins, erythromycins, tetracyclines, chloramphenicols, clindamycins, lincomycins, sulfonamides, and chemically modified equivalents and combinations thereof. 9. The medical device of claim 6, wherein said bio-active agent is selected from the group consisting of paclitaxel, docetaxel, mechlorethamine, chlorambucil, cyclophosphamide, melphalan, ifosfamide, methotrexate, 6-mercaptopurine, 5-fluorouracil, cytarabine, vinblastine, vincristine, etoposide, doxorubicin, daunomycin, bleomycin, mitomycin, carmustine, lomustine, cisplatin, interferon, angiostatin agents, endostatin agents, asparaginase, tamoxifen, flutamide, and chemically modified equivalents and combinations thereof. 10. The medical device of claim 6, wherein said bio-active agent is selected from the group consisting of amantadines, rimantadines, ribavirins, idoxuridines, vidarabines, trifluridines, acyclovirs, ganciclovirs, zidovudines, foscarnets, interferons, and chemically modified equivalents and combinations thereof. 11. The medical device of claim 1, wherein said surface is selected from the group consisting of polymers, ceramics, metals, glasses and combinations thereof. 12. The medical device of claim 1, wherein said surface is selected from the group consisting of polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroecthylene, polyvinyl acetate, polystyrene, poly(ethylene terephthalate), polyurethane, polyurea, silicone rubbers, polyamides, polycarbonates, polyaldehydes, natural rubbers, polyether-ester copolymers, styrene-butadiene copolymers and combinations thereof. 13. The medical device of claim 1, wherein said surface is selected from the group consisting of methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxy-propylmethyl cellulose, hydroxpropylethyl cellulose, sodium carboxymethyl cellulose, hyaluronic acid, chondroitin sulfate, chitosan, dextran, xanthan, gellan, alginic acid, jota carrageenan, collagen, gelatin, elastin, albumin, poly(vinyl alcohol), poly(lactic acid), polyglycolic acid, poly-.epsilon.-caprolactone, polyanhydride, and copolymers and combinations thereof. 14. The medical device of claim 1, wherein said surface is selected from the group consisting of stainless steel, nitinol, tantalum, titanium, gold, silver, and alloys and combinations thereof. 15. The medical device of claim 1, wherein said medical device is suitable for implantation. 16. The medical device of claim 15, wherein said device is in the form a graft, a stent, a graft-stent combination or a catheter. 17. The medical device of claim 16, wherein said stent is in the form of a vascular stent, an esophageal stent, an urinary stent, a biliary stent or a colonic stent. 18. A medical device with enhanced thrombo-resistance comprising: a) a substrate having a surface to which a thrombo-resistant coating may be attached thereto; and b) a thrombo-resistant coating formed from an aqueous emulsion or dispersion of a polycarbonate-polyurethane polymer, said polycarbonate-polyurethane polymer having thereon an emulsifying agent which includes at least one organic acid functional group, said polycarbonate-polyurethane polymer being attached to said substrate surface. 19. The medical device of claim 18, wherein said polycarbonate-polyurethane composition is prepared by reacting a polyfunctional isocyanate with a polycarbonate diol. 20. A medical device having a surface rendered bio-compatible by means of a first coating layer, said first coating layer formed from an aqueous emulsion or dispersion of a polycarbonate-polyurethane polymer, said polycarbonate-polyurethane polymer having thereon an emulsifying agent which includes at least one organic acid functional group. 21. The device of claim 20, wherein said polymer further comprises a polyfunctional cross-linking agent. 22. The device of claim 21 further comprising a second coating layer of a bio-active agent covalently bonded to said first coating layer, said second coating formed by the process of a) applying an aqueous emulsion or dispersion of said bio-active agent having at least one organic acid functional group over said first layer; and b) drying said second layer to covalently bond said second layer to said first layer via said organic acid functional group on said second layer and said multifunctional cross-linking agent. 23. A medical device having a surface coated with a bio-active layer comprising the reaction product of a polycarbonate-polyurethane first layer having an internal emulsifying agent thereon and a polyfunctional cross-linking agent, and a bio-active agent second layer having at least one organic acid functional group. 24. The medical device of claim 1, wherein said surface is selected from the group consisting of polysaccharides, polypeptide, synthetic polymers and combinations thereof. 25. The medical device of claim 6, wherein said bio-active agent is selected from the group consisting of alkylating agents, antimetabolites, plant alkaloids, antibiotics, nitrosureas, inorganic ions, biological response modifiers, enzymes, hormones, chemically modified equivalents and mixtures thereof.

Details for Patent 6,197,051

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	01/16/1978		2017-06-18
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2017-06-18